Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03281369
Recruitment Status : Recruiting
First Posted : September 13, 2017
Last Update Posted : March 4, 2021
Sponsor:
Collaborators:
Halozyme Therapeutics
BioLineRx, Ltd.
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 11, 2023
Estimated Study Completion Date : February 11, 2023